Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19

Ewan C. Goligher(University Health Network), Allen Cheng(Providence Portland Medical Center), Tania Ahuja(NYU Langone Health), Maria M. Brooks, B. J. Hunt(Kings Health Partners), Jen‐Ting Chen(Albert Einstein College of Medicine), Lucy Z. Kornblith, Scott Berry(Queen's University), Lana A. Castelucci, Sweta Chekuri, Victor B. Talisa(University of Pittsburgh), Matthew D. Neal(University of Pittsburgh), Lindsay Bond, Patrick R. Lawler(University Health Network), Henny H. Billett, Lana A. Castellucci, Meredith Buxton(Center for Effective Global Action), Marc Carrier(University of Ottawa), Elizabeth Lorenzi(Berry & Associates (United States)), Anthony Gordon, Marc J. M. Bonten(University Medical Center Utrecht), Colin McArthur, Shailesh Bihari, Diptesh Aryal, Djillali Annane(Inserm), Bryan J. McVerry(University of Pittsburgh), Eric Leifer(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Lisa Baumann Kreuziger(Medical College of Wisconsin), Charlotte Bradbury(University of Bristol), Judith S. Hochman(Columbia University Irving Medical Center), Jeffrey S. Berger(Temple University), Farah Al-Beidh(Imperial College Healthcare NHS Trust), Steven Webb(St John of God Subiaco Hospital), Chung‐Chou Ho Chang(University of Pittsburgh), Lindsay R. Berry(Berry & Associates (United States)), Derek Angus, Yaseen M. Arabi(King Saud bin Abdulaziz University for Health Sciences), Zahra Bhimani(St. Michael's Hospital), Adrian Buzgau(Monash University), Ryan Zarychanski(CancerCare Manitoba), Frank Brunkhorst(Jena University Hospital), Thomas P. Jensen(National Hospital for Neurology and Neurosurgery), Abi Beane(University of Oxford), Aaron W. Aday(Vanderbilt University Medical Center)
JAMA
March 21, 2023
Cited by 98


Related Papers